Pharmacology & Physiology International Scientific Congress 2014 (28th MSPP Scientific Meeting)
Pharmacologists and physiologists met at the Putra World Trade Centre for three days of talks and posters, with a special focus on the heart and blood vessels. Prima Nexus supported it.
· Conference · Supported by Prima Nexus
About the congress
The Malaysian Society of Pharmacology and Physiology (MSPP) held its 28th Scientific Meeting as the Pharmacology & Physiology International Scientific Congress 2014 (PPISC 2014), from 22 to 24 August 2014 at the Putra World Trade Centre (PWTC) in Kuala Lumpur. It ran together with the 13th Symposium on Vascular Neuroeffector Mechanisms (VNEM), the 6th Scientific Meeting of the Asian Society for Vascular Biology (ASVB) and the Malaysian Society of Hypertension (MSH).
Topics, talks and posters
Besides the classic fields of pharmacology and physiology, the congress gave particular attention to the heart and blood vessels: how they work, how medicines act on them, and how cardiovascular disease is treated. Other topics were natural products and medicinal plants, and traditional and complementary medicine. Researchers presented talks and posters, and doctors and pharmacists who registered could earn continuing education points. On the last day, oral sessions ran in four rooms, including a young investigator award competition, before the prize-giving and closing ceremony.
Prima Nexus's part
Prima Nexus supported the congress, after the organising committee accepted its support in July 2014. It supported MSPP's scientific meetings again in 2016 and 2017. Teams that test new medicines in animal models can work with Prima Nexus on in vivo animal studies.
More of our work with MSPP, UM.
Read the story: Prima Nexus supported meetings on cancer, microscopy, pharmacology, drug delivery and tissue engineering in 2014.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.
